Skip to main content
. 2023 Aug 21;38(1):2244693. doi: 10.1080/14756366.2023.2244693

Figure 1.

Figure 1.

The strategy for the development of SARS-CoV-2 S protein-human ACE2 interaction inhibitors based on peptide foldamers.